Acrivon Therapeutics News

Acrivon Therapeutics | ARS: Annual Report to Security Holders

Apr 26 20:38

Acrivon Therapeutics | DEFA14A: Others

Apr 26 20:38

Acrivon Therapeutics | DEF 14A: Definitive information statements

Apr 26 20:33

Acrivon Therapeutics | 8-K: Current report

Apr 25 04:06

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Mary

Apr 20 04:15

Acrivon Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Apr 18 04:41

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.

Apr 16 04:20

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner PERCEPTIVE ADVISORS LLC

Apr 15 20:58

Acrivon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(17.4%),Joseph Edelman(17.4%), etc.

Apr 15 20:23

Acrivon Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(27.1%),Peter Kolchinsky(27.1%), etc.

Apr 12 04:22

Acrivon Therapeutics | 8-K: Current report

Apr 9 19:09

Acrivon Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 29 21:07

Acrivon Therapeutics | 8-K: Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Mar 28 20:04

Acrivon Therapeutics | 10-K: Annual report

Mar 28 19:39

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Palani Santhosh

Mar 7 05:36

Acrivon Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Palani Santhosh

Mar 7 05:31

Acrivon Therapeutics | 8-K: Current report

Mar 4 21:20

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Masson Kristina

Feb 17 06:19

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Mary

Feb 17 06:18

Acrivon Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Holm-Jorgensen Rasmus

Feb 17 06:17